Microarrays Inc. | GenomeWeb

Microarrays Inc.

Microarrays Inc. is now offering custom laboratory services for gene expression projects.

New Product Watch

Premium

Microarrays Inc. this week launched three MI PathArray assays for studying targeted biological pathways. The new arrays cover pathways associated with apoptosis, growth factors, and inflammation.

The Huntsville, Ala.-based firm has tapped Cambio to distribute its products in the UK and Ireland; BioCat to cover Germany, Austria, and Switzerland; and Biosolutions to sell its arrays to customers in Cyprus, Greece, and other Balkan countries.

People in the News

Premium

Erik Holmlin, Edward Erickson, Andrew Jennings

The new corporate structure will allow Microarrays to "quickly and nimbly" respond to the growing needs of customers, especially in the diagnostics and healthcare markets, the company said in a statement.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.